AI assistant
Sending…
SPRUCE BIOSCIENCES, INC. — Director's Dealing 2020
Oct 9, 2020
35408_dirs_2020-10-08_3b696f3a-dd1f-4166-9767-2489cb1c3d8f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SPRUCE BIOSCIENCES, INC. (SPRB)
CIK: 0001683553
Period of Report: 2020-10-08
Reporting Person: Gharib Samir M. (Chief Financial Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.64 | 2030-06-07 | Common Stock (118483) | Direct | |
| Stock Option (Right to Buy) | $3.07 | 2030-08-06 | Common Stock (71548) | Direct |
Footnotes
F1: The shares subject to the stock option are early exercisable, subject to the Issuer's right of repurchase, and vest over a four-year period commencing May 1, 2020, with 1/4th of the shares vesting on May 1, 2021 and 1/36th of the remaining shares vesting on a monthly basis.
F2: The shares subject to the stock option are early exercisable, subject to the Issuer's right of repurchase, and vest over a four-year period commencing August 7,2020, with 1/48th of the shares vesting on a monthly basis.
More from SPRUCE BIOSCIENCES, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
May 26
Earnings Release
2026
May 13
Capital/Financing Update
2026
Apr 21
Capital/Financing Update
2026
Apr 20
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17